Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Imifoplatin | 1339960-28-9 | 95.0% | 485.23 | 50 MG
SDP

Catalog No. 5000343726
Encompass_Preferred

Imifoplatin (PT-112) is a platinum-based active molecule and a member of the phosphaplatins family. Imifoplatin can induce Apoptosis and exhibits antitumor activity.

  • Inhibits proliferation in HCT116 cells.
  • Induces apoptosis in HCT116 cells.
  • Inhibits proliferation in CT26 cells.
  • Shows selectivity, strongly inhibiting glycolytic tumor cells with mtDNA mutations.
  • Increases mtROS, especially in glycolytic L929dt and Cybrid cells.
  • Demonstrates potent antitumor immune effects in the CT26 xenograft model.
  • Shows synergistic antitumor effects in the MC38 xenograft model, especially with PD-1 blockade.

Catalog No. 50-003-43726 Supplier Medchemexpress LLC Supplier No. HY10914650MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Imifoplatin (PT-112) is a platinum-based active molecule and a member of the phosphaplatins family. Imifoplatin can induce Apoptosis and exhibits antitumor activity.

  • Inhibits proliferation in HCT116 cells.
  • Induces apoptosis in HCT116 cells.
  • Inhibits proliferation in CT26 cells.
  • Shows selectivity, strongly inhibiting glycolytic tumor cells with mtDNA mutations.
  • Increases mtROS, especially in glycolytic L929dt and Cybrid cells.
  • Demonstrates potent antitumor immune effects in the CT26 xenograft model.
  • Shows synergistic antitumor effects in the MC38 xenograft model, especially with PD-1 blockade.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.